Education
About Us
Working with TipRanks
Follow Us
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
RESEARCH TOOLSreports
LEXT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.09 - C$1.10
Previous CloseN/A
Volume1.00M
Average Volume (3M)5.09K
Market Cap
C$1.03M
Enterprise ValueC$25.73M
Total Cash (Recent Filing)C$63.58K
Total Debt (Recent Filing)C$60.00K
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Sep 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding7,362,600
10 Day Avg. Volume7,342
30 Day Avg. Volume5,090
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)32.67
Price to Sales (P/S)0.00
P/FCF Ratio-26.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lexston Life Sciences Corp. News
PremiumCompany Announcements
Lexston Mining Corporation Secures $196,000 in Private Placement
PremiumCompany Announcements
Lexston Mining Corporation Launches Private Placement for Strategic Growth
PremiumCompany Announcements
Lexston Mining Corporation Cancels 442,500 Stock Options
PremiumCompany Announcements
Lexston Mining Completes Share Consolidation to Optimize Share Structure
PremiumCompany Announcements
Lexston Mining Announces Share Consolidation to Streamline Operations
PremiumCompany Announcements
Lexston Mining Extends Key Property Agreements to Boost Exploration Efforts
PremiumCompany Announcements
Lexston Mining Delays Annual Meeting Amid Postal Strike
PremiumCompany Announcements
Lexston Life Sciences Reports Uranium Exploration ProgressOptions Prices
Currently, No data available
---
Ownership Overview
33.45% Insiders
―
Mutual Funds
0.09% Other Institutional Investors
66.46% Public Companies and
Individual Investors
LEXT FAQ
What was Lexston Life Sciences Corp.’s price range in the past 12 months?
Lexston Life Sciences Corp. lowest stock price was C$0.09 and its highest was C$1.10 in the past 12 months.
What is Lexston Life Sciences Corp.’s market cap?
Lexston Life Sciences Corp.’s market cap is C$1.03M.
When is Lexston Life Sciences Corp.’s upcoming earnings report date?
Lexston Life Sciences Corp.’s upcoming earnings report date is Sep 22, 2025 which is in 94 days.
How were Lexston Life Sciences Corp.’s earnings last quarter?
Lexston Life Sciences Corp. released its earnings results on Apr 04, 2025. The company reported -C$0.052 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.052.
Is Lexston Life Sciences Corp. overvalued?
According to Wall Street analysts Lexston Life Sciences Corp.’s price is currently Overvalued.
Does Lexston Life Sciences Corp. pay dividends?
Lexston Life Sciences Corp. does not currently pay dividends.
What is Lexston Life Sciences Corp.’s EPS estimate?
Lexston Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lexston Life Sciences Corp. have?
Lexston Life Sciences Corp. has 7,362,600 shares outstanding.
What happened to Lexston Life Sciences Corp.’s price movement after its last earnings report?
Lexston Life Sciences Corp. reported an EPS of -C$0.052 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lexston Life Sciences Corp.?
Currently, no hedge funds are holding shares in TSE:LEXT
Company Description
Lexston Life Sciences Corp.
Lexston Life Sciences Corp. operates as a biotechnology company that provides cannabis testing and research services in Canada. The company also offers analytical testing for cannabis, pathogens, and toxins. In addition, it focuses on developing and validating methods for standardized manufacturing of plant derived psychedelics in the field of mental health and wellness. The company is based in Vancouver, Canada.
Technical Analysis
Braxia Scientific
―
Entheon Biomedical
―
Awakn Life Sciences
―
Doseology Sciences
―
GeneTether Therapeutics, Inc.
―